Search results
Johnson & Johnson Highlights Commitment to Transform Treatment of Retinal Diseases at ARVO 2024
WKRN Nashville· 5 days agoJohnson & Johnson today announced that eight company-sponsored presentations will be featured during the Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting taking ...
TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk...
WTNH-TV New Haven· 4 days agoJohnson & Johnson announced today updated results from Cohort 2 of the Phase 2b SunRISe-1 study...
AP Trending SummaryBrief at 6:12 p.m. EDT
The Meridian Star· 5 days agoArtists from Universal Music Group, which include Drake, Adele, Bad Bunny and Billie Eilish, will be returning to TikTok as the two parties have struck a new licensing agreement following an ...
TAR-200 monotherapy shows greater than 80% complete response rate in patients with high-risk...
The Longview News-Journal· 4 days agoJohnson & Johnson announced today updated results from Cohort 2 of the Phase 2b SunRISe-1 study evaluating the efficacy and safety of investigational TAR-200 monotherapy in patients with BCG-unresponsive ...